Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orlistat

REVIVE

Empros Pharma AB · Phase 2 · Terminated · Enrollment 128

NCT01351753

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Metforminn/rn/rn/rn/rn/r
Metformin + Orlistatn/rn/rn/rn/rn/r
Metformin + Topiramaten/rn/rn/rn/rn/r
Topiramaten/rn/rn/rn/rn/r
Metformin + Topiramate + Orlistatn/rn/rn/rn/rn/r
Placebon/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.